Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

CompletedOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Prostatic Cancer
Trial Locations (33)

Unknown

Research Site, Albacete

Research Site, El Ejido

Research Site, Huercal Overa

Research Site, Mérida

Research Site, Palma de Mallorca

Research Site, Barcelona

Research Site, El Hospitalet de Llobregat

Research Site, Sabadell

Research Site, Aranda de Duero

Research Site, Miranda de Ebro

Research Site, Córdoba

Research Site, Ferrol

Research Site, Granada

Research Site, Guadalajara

Research Site, Donostia / San Sebastian

Research Site, Jaén

Research Site, Logroño

Research Site, Monforte (casco Urbano)

Research Site, Alcalá de Henares

Research Site, Coslada

Research Site, Madrid

Research Site, Majadahonda

Research Site, San Sebastián de los Reyes

Research Site, Antequera

Research Site, Vigo

Research Site, Osuna

Research Site, Reus

Research Site, Toledo

Research Site, Barakaldo

Research Site, Bilbao

Research Site, Galdakao

Research Site, Calatayud

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY